Merck (MRK) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $307.27B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | US | CEO | Robert Davis |
| IPO Date | 1978-01-13 | CAGR | 7.54% |
| Employees | 75,000 | Website | www.merck.com |
| Div. Yield | 3.85% | Payout Ratio | 92.12% |
| Buy Back Yield | 0.48% | Total Yield | 4.33% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| Enterprise Value | $346.09B | P/E Ratio | 22.74 |
| Forward P/E | 12.88 | PEG Ratio | — |
| P/S Ratio | 3.35 | P/B Ratio | 4.79 |
| P/CF Ratio | 12.28 | P/FCF Ratio | 15.54 |
| EPS | $5.47 | EPS Growth 1Y | -48.33% |
| EPS Growth 3Y | -30.66% | EPS Growth 5Y | 28.16% |
| Revenue Growth 1Y | 2.47% | Gross Margin | 0.76% |
| Operating Margin | 0.28% | Profit Margin | 0.14% |
| ROE | 0.18% | ROA | 0.07% |
| ROCE | 0.18% | Current Ratio | 1.3 |
| Quick Ratio | 1.06 | Cash Ratio | 0.2 |
| Debt/Equity | 1.07 | Interest Coverage | 17.35 |
| Altman Z Score | 4 | Piotroski Score | 6 |
Merck (MRK) valuation & financials
Merck (MRK) has a market capitalization of $307.27B and trades at a price-to-earnings ratio of 22.7. It operates in the Healthcare sector (Drug Manufacturers - General).
Merck's revenue grew +2.5% over the last year.
Merck's next earnings report is scheduled for August 4, 2026 before market open; analysts estimate EPS of $2.27.
Merck (MRK) — frequently asked questions
When does Merck (MRK) report earnings next?
Merck is expected to report earnings on August 4, 2026 before market open. Analysts estimate EPS of $2.27.
What is Merck's market cap?
Merck (MRK) has a market capitalization of $307.27B.
What is MRK's P/E ratio?
Merck trades at a price-to-earnings ratio of 22.7, with trailing twelve-month EPS of $5.47.
How fast is Merck growing?
Merck's revenue grew +2.5% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Novartis (NVS)